Precision medicine approaches in oncology therapeutic development depend on a comprehensive understanding of each patient's tumor and tumor microenvironment, but developing this detailed profile can be challenging, especially when only limited biopsy sample may be available for analysis.

In this white paper we explore :

• The role of the tumor microenvironment (TME) in cancer progression

• Methods for biopsy analysis and the emerging role of quantitative multiplex immunofluorescence

• How to maximize the utility of quantitative multiplex immunofluorescence for tumor profiling